Background
Methods
Study population
MA substudy
Clinical examination and laboratory procedures
Dementia ascertainment
Urine sampling
Follow-up and endpoints
Data analysis
Results
eGFR
HUNT 2 (1995–1997) | No dementia | Total Dementia | Combined AD/VaD/Mixed AD/VaD | AD | VaD | Mixed AD/VaD | Other Dementia |
P value
A
|
---|---|---|---|---|---|---|---|---|
Total study population, n | 47,840 | 668 | 528 | 348 | 112 | 68 | 140 | |
eGFR, mean (SD) | 78.99 (16.15) | 63.89 (12.39) | 63.13 (12.40) | 62.79 (12.12) | 64.97 (14.39) | 61.88 (9.84) | 66.74 (11.91) |
.00
|
4 stages eGFR, n (%) |
.00
| |||||||
> 90 | 11,708 (24.5) | 16 (2.4) | 12 (2.3) | 8 (2.3) | 4 (3.6) | 0 | 4 (2.9) | |
60.0–89.9 | 30,347 (63.4) | 397 (59.4) | 306 (58.0) | 196 (56.3) | 68 (60.7) | 42 (61.8) | 91 (65.0) | |
30.0–59.9 | 5697 (11.9) | 251 (37.6) | 207 (39.2) | 143 (41.1) | 38 (33.9) | 26 (38.2) | 44 (31.4) | |
< 30 | 88 (.2) | 4 (.6) | 3 (.6) | 1 (.3) | 2 (1.8) | 0 | 1 (.7) | |
Diabetes Mellitus, n (%) | 1307 (2.7) | 34 (5.1) | 31 (5.9) | 18 (5.2) | 8 (7.1) | 5 (7.4) | 3 (2.1) |
.00
|
Anti-hypertensive tablets, ever, n (%) | 6476 (13.5) | 211 (31.6) | 173 (32.8) | 102 (29.3) | 48 (42.9) | 23 (33.8) | 38 (27.1) |
.00
|
Sex, Female, n (%) | 25,806 (53.9) | 410 (61.4) | 341 (64.6) | 238 (68.4) | 58 (51.8) | 45 (66.2) | 69 (49.3) |
.00
|
Age at HUNT 2 (1995–1997), mean (SD) | 49.24 (16.55) | 70.58 (7.54) | 71.26 (6.99) | 71.62 (6.80) | 69.82 (8.19) | 71.84 (5.38) | 68.02 (8.93) |
.00
|
Time to debut, years, mean (SD) | 7.15 (3.63) | 7.15 (3.65) | 7.20 (3.76) | 7.41 (3.53) | 6.45 (3.16) | 7.16 (3.57) | ||
Education, n (%) |
.00
| |||||||
Primary | 17,234 (36.0) | 458 (68.6) | 367 (69.5) | 240 (69.0) | 77 (68.8) | 50 (73.5) | 91 (65.0) | |
Completed secondary | 26,830 (56.1) | 195 (29.2) | 151 (28.6) | 104 (29.9) | 30 (26.8) | 17 (25.0) | 44 (31.4) | |
Completed upper secondary | 3776 (7.9) | 15 (2.2) | 10 (1.9) | 4 (1.1) | 5 (4.5) | 1 (1.5) | 5 (3.6) | |
Cholesterol (mmol/L), mean (SD) | 5.87 (1.25) | 6.65 (1.24) | 6.70 (1.24) | 6.72 (1.23) | 6.65 (1.5) | 6.64 (1.29) | 6.46 (1.21) |
.00
|
Non-fasting blood glucose (mmol/L), mean (SD) | 5.42 (1.46) | 5.88 (1.78) | 5.91 (1.79) | 5.89 (1.85) | 6.03 (1.84) | 5.77 (1.37) | 5.78 (1.74) |
.00
|
Serum iron (), mean (SD) | 16.51 (6.31) | 16.08 (5.74) | 15.99 (5.79) | 16.07 (5.89) | 15.55 (5.71) | 16.28 (5.55) | 16.45 (5.58) |
.06
|
Body Mass Index (kg/m2) mean (SD) | 26.32 (4.07) | 27.03 (4.11) | 26.96 (4.04) | 26.76 (4.03) | 27.62 (4.39) | 26.91 (3.34) | 27.28 (4.36) |
.00
|
Pulse (beats/min), mean (SD) | 72.96 (12.56) | 73.63 (13.87) | 73.70 (13.71) | 73.77 (14.44) | 72.41 (11.77) | 75.50 (12.72) | 73.36 (14.53) |
.21
|
Systolic BP (mmHg), mean (SD) | 136.86 (21.23) | 153.27 (23.23) | 153.94 (23.52) | 153.96 (23.63) | 153.63 (22.17) | 154.34 (25.34) | 150.72 (21.99) |
.00
|
Diastolic BP (mmHg), mean (SD) | 80.02 (12.01) | 84.68 (12.56) | 84.73 (12.56) | 83.97 (12.50) | 86.47 (12.27) | 85.69 (13.13) | 84.50 (12.62) |
.00
|
Myocardial Infarction, n (%) | 1444 (3.0) | 40 (6.0) | 32 (6.1) | 18 (5.2) | 10 (8.9) | 4 (5.9) | 8 (5.7) |
.00
|
Angina Pectoris, n (%) | 2178 (4.6) | 90 (13.5) | 71 (13.4) | 46 (13.2) | 15 (13.4) | 10 (14.7) | 19 (13.6) |
.00
|
Stroke, n (%) | 809 (1.7) | 25 (3.7) | 21 (4.0) | 7 (2.0) | 12 (10.7) | 2 (2.9) | 4 (2.9) |
.00
|
Daily Smoker, n (%) | 13,425 (28.1) | 110 (16.5) | 80 (15.2) | 44 (12.6) | 25 (22.3) | 11 (16.2) | 30 (21.4) |
.00
|
Subjective health status |
.00
| |||||||
Poor, n (%) | 752 (1.6) | 13 (1.9) | 12 (2.3) | 7 (2.0) | 5 (4.5) | 0 | 1 (.7) | |
Not so good, n (%) | 11,646 (24.3) | 303 (45.4) | 239 (45.3) | 149 (42.8) | 55 (49.1) | 35 (51.5) | 64 (45.7) | |
Good, n (%) | 27,659 (57.8) | 323 (48.4) | 260 (49.2) | 181 (52.0) | 47 (42.0) | 32 (47.1) | 63 (45.0) | |
Very good, n (%) | 7783 (16.3) | 29 (4.3) | 17 (3.2) | 11 (3.2) | 5 (4.5) | 1 (1.5) | 12 (8.6) |
Total Dementia | NCA | Combined AD, VaD, Mixed AD/VaD | NC | AD | NC | VaD | NC | Mixed AD/VaD | NC | Other Dementia | NC | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
eGFR | 668 | 528 | 348 | 112 | 68 | 140 | |||||||
Model 1c | > 90 | Ref | Ref | Ref | Ref | Ref | Ref | ||||||
69.0–89.9 | 9.96 (6.04–16.42) | 10.52 (5.76–18.26) | 9.88 (4.87–20.03) | 6.86 (2.50–18.81) | not sig | 9.17 (3.37–24.96) | |||||||
30.0–59.9 | 41.73 (25.17–69.19) | 46.10 (25.75–82.51) | 48.22 (23.65–98.31) | 26.10 (9.31–73.17) | not sig | 29.77 (10.69–82.88) | |||||||
< 30 | 62.85 (21.00–188.06) | 63.22 (17.83–224.14) | 32.70 (4.09–261.59) | 131.97 (24.14–721.62) | not sig | 65.94 (7.36–590.56) | |||||||
Model 2d | > 90 | Ref | Ref | Ref | Ref | Ref | Ref | ||||||
69.0–89.9 | 1.38 (.82–2.34) | 1.24 (.68–2.26) | 1.09 (.52–2.29) | 1.08 (.37–3.16) | not sig | 2.03 (.71–5.80) | |||||||
30.0–59.9 | 1.24 (.71–2.16) | 1.09 (.58–2.07) | .98 (.45–2.15) | .97 (.30–3.13) | not sig | 1.87 (.60–5.82) | |||||||
< 30 | 1.68 (.55–5.17) | 1.37 (.38–5.02) | .62 (.08–5.10) | 4.16 (.69–24.99) | not sig | 3.50 (.37–33.22) | |||||||
Model 3e | > 90 | Ref | Ref | Ref | Ref | Ref | Ref | ||||||
69.0–89.9 | 1.35 (.80–2.28) | 1.20 (.65–2.20) | 1.08 (.51–2.28) | .97 (.33–2.83) | not sig | 2.00 (.70–5.74) | |||||||
30.0–59.9 | 1.20 (.68–2.10) | 1.05 (.55–2.00) | .98 (.44–2.16) | .81 (.25–2.63) | not sig | 1.82 (.58–5.71) | |||||||
< 30 | 1.64 (.53–5.05) | 1.34 (.37–4.92) | .64 (.08–5.33) | 3.10 (.51–18.79) | not sig | 3.43 (.36–32.72) | |||||||
Model 4f | > 90 | Ref | Ref | Ref | Ref | Ref | Ref | ||||||
69.0–89.9 | 1.34 (.79–2.26) | 1.18 (.64–2.16) | 1.06 (.50–2.22) | .97 (.33–2.83) | not sig | 2.04 (.71–5.82) | |||||||
30.0–59.9 | 1.17 (.67–2.06) | 1.02 (.54–1.94) | .96 (.43–2.12) | .75 (.23–2.44) | not sig | 1.84 (.59–5.81) | |||||||
< 30 | 1.57 (.51–4.85) | 1.24 (.34–4.58) | .65 (.08–5.35) | 2.29 (.37–14.08) | not sig | 3.69 (.38–35.55) | |||||||
eGFR*Age | |||||||||||||
> 90 |
Ref
|
Ref
|
Ref
|
Ref
|
Ref
|
Ref
| |||||||
69.0–89.9 | .95 (.91–.99) |
.97 (.92–1.02)
|
.96 (.90–1.02)
| .99 (.90–1.10) |
not sig
| .90 (.82–.99) | |||||||
30.0–59.9 | .90 (.86–.94) | .91 (.86–.96) | .90 (.84–.96) | .96 (.6–1.06) |
not sig
| .85 (.77–.94) | |||||||
< 30 | .88 (.79–.98) | .88 (.78–.98) |
.88 (.72–1.07)
| .91 (.77–1.06) |
not sig
|
.92 (.69–1.22)
| |||||||
eGFR*Sex | |||||||||||||
> 90 |
Ref
|
Ref
|
Ref
|
Ref
|
Ref
|
Ref
| |||||||
69.0–89.9 |
1.98 (.72–5.44)
| 3.25 (1.01–10.49) |
2.15 (.52–8.85)
|
9.98 (.98–101.33)
|
not sig
|
not sig
| |||||||
30.0–59.9 |
1.67 (.59–4.69)
|
2.80 (.85–9.30)
|
1.34 (.31–5.80)
| 17.33 (1.63–183.87) |
not sig
|
not sig
| |||||||
< 30 |
2.58 (.29–23.32)
|
9.41 (.65–135.41)
|
.00 (.00–.00)
|
.00 (.00–.00)
|
not sig
|
not sig
|
MA substudy
HUNT 2 (1995–1997) | No dementia | Total Dementia | Combined AD/VaD/Mixed AD/VaD | AD | VaD | Mixed AD/VaD | Other Dementia |
P value
A
|
---|---|---|---|---|---|---|---|---|
Total Sample | 6810 | 214 | 176 | 109 | 44 | 23 | 38 | |
ACR, mg/mmol mean (SD) | 1.70 (3.06) | 1.94 (3.37) | 1.95 (3.47) | 2.27 (4.31) | 1.68 (1.20) | .97 (.50) | 1.87 (2.89) |
.26
|
ACR, quartiles, n (%) |
.01
| |||||||
0–.53 | 1561 (22.9) | 32 (15.0) | 25 (14.2) | 18 (16.5) | 4 (9.1) | 3 (13.0) | 7(18.4) | |
.54–.87 | 2232 (32.8) | 70 (32.7) | 58 (33.0) | 36 (33.0) | 10 (22.7) | 12 (52.2) | 12 (31.6) | |
.88–1.77 | 1695 (24.9) | 55 (25.7) | 47 (26.7) | 26 (23.9) | 14 (31.8) | 7 (30.4) | 8 (21.1) | |
1.78+ | 1322 (19.4) | 57 (26.6) | 46 (26.1) | 29 (26.6) | 16 (36.4) | 1 (4.3) | 11 (28.9) | |
Diabetes Mellitus, n (%) | 1075 (15.8) | 31 (14.5) | 28 (15.9) | 16 (14.7) | 7 (15.9) | 5 (21.7) | 3 (7.9) |
.61
|
Antihypertensive tablets, n (%) | 4569 (67.1) | 168 (78.5) | 136 (77.3) | 80 (73.4) | 40 (90.9) | 16 (69.6) | 32 (84.2) |
.00
|
Sex, Female, n (%) | 3665 (53.8) | 133 (62.1) | 114 (64.8) | 77 (70.6) | 22 (50.0) | 15 (65.2) | 19 (50.0) |
.02
|
Age at HUNT 2 (1995–1997), mean (SD) | 60.44 (14.74) | 71.16 (6.49) | 71.67 (6.43) | 72.06 (6.16) | 70.40 (7.25) | 72.27 (5.91) | 68.80 (6.37) |
.00
|
Time to debut, years, mean (SD) | 7.16 (3.74) | 7.19 (3.85) | 7.25 (4.03) | 7.30 (3.82) | 6.69 (3.06) | 7.00 (3.22) | ||
Education, n (%) |
.01
| |||||||
Primary | 3766 (55.3) | 141 (65.9) | 120 (68.2) | 76 (69.7) | 28 (63.6) | 16 (69.6) | 21 (55.3) | |
Completed secondary | 2726 (40.0) | 68 (31.8) | 51 (29.0) | 32 (29.4) | 12 (27.3) | 7 (30.4) | 17 (44.7) | |
Completed upper secondary | 318 (4.7) | 5 (2.3) | 5 (2.8) | 1 (.9) | 4 (9.1) | 0 | 0 | |
eGFR, mean (SD) | 69.89 (15.63) | 61.31 (12.76) | 60.52 (12.53) | 59.92 (11.76) | 62.53 (15.31) | 59.55 (10.05) | 64.96 (13.34) |
.00
|
Cholesterol (mmol/L), mean (SD) | 6.24 (1.25) | 6.69 (1.28) | 6.78 (1.24) | 6.87 (1.25) | 6.70 (1.19) | 6.48 (1.25) | 6.27 (1.42) |
.00
|
Non-fasting blood glucose (mmol/L), mean (SD) | 6.19 (2.44) | 6.30 (2.34) | 6.28 (2.26) | 6.36 (2.45) | 6.19 (2.00) | 6.05 (1.79) | 6.42 (2.73) |
.51
|
Serum iron (), mean (SD) | 16.36 (5.98) | 15.62 (5.50) | 15.32 (5.26) | 15.47 (5.19) | 15.34 (5.57) | 14.57 (5.17) | 17.00 (6.38) |
.07
|
BMI (kg/m2) mean (SD) | 28.03 (4.54) | 28.29 (4.31) | 28.43 (4.20) | 28.31 (4.04) | 29.11 (4.92) | 27.74 (3.44) | 27.61 (4.78) |
.41
|
Pulse (beats/min), mean (SD) | 72.40 (13.64) | 72.38 (13.64) | 72.23 (12.77) | 72.06 (12.88) | 71.99 (1.78) | 73.52 (14.47) | 73.05 (17.31) |
.98
|
Systolic BP (mmHg), mean (SD) | 149.65 (23.29) | 159.80 (24.26) | 160.01 (21.19) | 159.48 (23.49) | 160.09 (24.45) | 162.35 (27.74) | 158.84 (24.90) |
.00
|
Diastolic BP (mmHg), mean (SD) | 85.27 (12.58) | 88.34 (13.13) | 88.22 (12.53) | 87.24 (12.59) | 90.36 (12.23) | 88.74 (12.76) | 88.89 (15.81) |
.00
|
Myocardial Infarction, n (%) | 581 (8.5) | 19 (8.9) | 13 (7.4) | 10 (9.2) | 3 (6.8) | 0 | 6 (15.8) |
.86
|
Angina Pectoris, n (%) | 918 (13.5) | 35 (16.4) | 27 (15.3) | 20 (18.3) | 4 (9.1) | 3 (13.0) | 8 (21.1) |
.23
|
Stroke, n (%) | 332 (4.9) | 16 (7.5) | 14 (8.0) | 5 (4.6) | 8 (18.2) | 1 (4.3) | 2 (5.3) |
.08
|
Daily Smoker, n (%) | 1347 (19.8) | 30 (14.0) | 24 (13.6) | 13 (11.9) | 8 (18.2) | 3 (13.0) | 6 (15.8) |
.04
|
Subjective health status |
.01
| |||||||
Poor, n (%) | 190 (2.8) | 5 (2.3) | 5 (2.8) | 3 (2.8) | 2 (4.5) | 0 | 0 | |
Not so good, n (%) | 2739 (40.2) | 106 (49.5) | 84 (47.7) | 49 (45.0) | 22 (50.0) | 13 (56.5) | 22 (57.9) | |
Good, n (%) | 3458 (50.8) | 98 (45.8) | 84 (47.7) | 55 (50.5) | 19 (43.2) | 10 (43.5) | 14 (36.8) | |
Very good, n (%) | 423 (6.2) | 5 (2.3) | 3 (1.7) | 2 (1.8) | 1 (2.3) | 0 | 2 (5.3) |
Total Dementia | NCA | Combined AD, VaD, Mixed AD/VaD | NC | AD | NC | VaD | NC | Mixed AD/VaD | NC | Other Dementia | NC | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
DM or HTN medicationB | ACR | 184 | 151 | 90 | 42 | 19 | 33 | ||||||
Model 1C | 0–.53 | Ref | Ref | Ref | Ref | Ref | Ref | ||||||
.54–.87 | 1.43 (.90–2.28) | 1.64 (.96–2.80) | 1.31 (.67–2.56) | 2.03 (.55–7.51) | 3.41 (.75–15.58) | .88 (.33–2.36) | |||||||
.88–1.77 | 1.57 (.98–2.53) |
1.84 (1.07–3.16)
| 1.31 (.67–2.56) |
3.89 (1.12–13.53)
| 2.51 (.51–12.46) | .84 (.30–2.41) | |||||||
1.78+ |
2.29 (1.43–3.65)
|
2.55 (1.49–4.38)
|
2.14 (1.12–4.09)
|
5.92 (1.72–20.33)
| .55 (.05–6.12) | 1.59 (.61–4.19) | |||||||
Model 2D | 0–.53 | Ref | Ref | Ref | Ref | Ref | Ref | ||||||
.54–.87 | 1.36 (.85–2.17) | 1.56 (.91–2.66) | 1.25 (.66–2.39) | 1.93 (.52–7.13) | 3.19 (.70–14.57) | .84 (.31–2.26) | |||||||
.88–1.77 | 1.24 (.77–2.01) | 1.44 (.83–2.48) | 1.01 (.52–1.98) | 3.24 (.93–11.34) | 1.79 (.36–8.96) | .70 (.24–2.01) | |||||||
1.78+ |
1.71 (1.06–2.75)
|
1.89 (1.10–3.26)
| 1.60 (.83–1.98) |
4.52 (1.30–15.72)
| .37 (.36–8.96) | 1.24 (.46–3.31) | |||||||
Model 3E | 0–.53 | Ref | Ref | Ref | Ref | Ref | Ref | ||||||
.54–.87 | 1.38 (.86–2.20) | 1.59 (.93–2.73) | 1.28 (.67–2.46) | 1.94 (.52–7.18) | 3.29 (.72–15.16) | .82 (.30–2.21) | |||||||
.88–1.77 | 1.22 (.75–1.98) | 1.44 (.83–2.49) | 1.04 (.52–2.04) | 3.13 (.89–11.04) | 1.69 (.33–8.54) | .65 (.22–1.88) | |||||||
1.78+ |
1.66 (1.03–2.69)
|
1.87 (1.08–3.25)
| 1.61 (.83–3.13) |
4.35 (1.24–15.28)
| .34 (.03–3.86) | 1.12 (.41–3.04) | |||||||
Model 4F | 0–.53 | Ref | Ref | Ref | Ref | Ref | Ref | ||||||
.54–.87 | 1.38 (.86–2.21) | 1.60 (.93–2.74) | 1.30 (.68–2.50) | 1.82 (.49–6.76) | 3.78 (.82–17.54) | .83 (.31–2.24) | |||||||
.88–1.77 | 1.23 (.76–2.00) | 1.46 (.84–2.53) | 1.07 (.54–2.12) | 2.93 (.83–10.40) | 1.87 (.37–9.53) | .61 (.21–1.78) | |||||||
1.78+ |
1.65 (1.02–2.69)
|
1.85 (1.06–3.23)
| 1.66 (.85–3.24) |
3.97 (1.12–14.07)
| .36 (.03–4.08) | 1.12 (.41–3.09) | |||||||
ACR*Age |
.11
|
.09
|
.91
|
.15
|
.24
|
.86
| |||||||
ACR*Sex |
.46
|
.38
|
.44
|
.77
|
.20
|
.09
|